The Paris Prospective Study is a long-term investigation of the incidence of coronary heart disease in a large population of working men. The first follow-up examination involved 7,038 men, aged 43-54 years. Subjects with impaired glucose tolerance or diabetes (n = 943) were selected from the total population for a separate analysis of coronary heart disease mortality risk factors. During a mean follow-up of 11 years, 26 of these 943 subjects with abnormal glucose tolerance died from coronary heart disease. Univariate analysis showed that plasma triglyceride level (p < 0.006), plasma cholesterol level (p< 0.02), and plasma insulin level both fasting and 2-h post-glucose load (p< 0.02), were significantly higher in subjects who died from coronary heart disease compared to those who did not. In multivariate regression analysis using the Cox model, plasma triglyceride level was the only factor positively and significantly associated with coronary death. The distribution of plasma triglyceride levels was clearly higher for the subjects who died from coronary heart disease compared to those who did not die from this cause or were alive at the end of the follow-up. This new epidemiological evidence that hypertriglyceridaemia is an important predictor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes suggests a possible role of dyslipidaemia in the excessive occurrence of atherosclerotic vascular disease in this category of subjects.
Diabetic subjects are known to have a high frequency of atherosclerosis [1] , but the underlying mechanism remains unclear. Hyperglycaemia, on which the definition of the disease is based [2] , may well not be a direct determinant of the atherosclerotic lesions of diabetes, since the incidence of cardiovascular events in diabetic subjects is not strictly related to the duration of hyperglycaemia [3, 4] . Furthermore, three large prospective surveys on the risk factors of coronary heart disease, independently initiated in the late sixties in Finland [5] , Australia [6] and France [7, 8] , showed, after 5 to 10 years follow-up, that high insulin levels in healthy men were predictive of coronary heart disease (CHD), even after adjustment for the classical risk factors (age, blood pressure, smoking habits, plasma cholesterol), whereas hyperglycaemia and diabetes were not independent predictors. Many studies have shown the close metabolic interdependence between carbohydrates and lipids [9, 10] . Plasma insulin is also a strong correlate of plasma lipids, especially HDL-cholesterol and triglyceride [11] [12] [13] [14] , and it is now well established that plasma insulin levels are generally higher in subjects with Type 2 (non-insulin-dependent) diabetes compared to non-diabetic subjects [15] . The aim of the present work, based on the data of the Paris Prospective Study, was to analyse further the respective and interactive roles of insulin, glucose tolerance, cholesterol and triglyceride plasma levels on the risk of CHD mortality.
Subjects and methods
Subjects selected in the present analysis were drawn from the population of the Paris Prospective Study. The general aims, detailed methodology and population characteristics of the Paris Prospective Study have been previously described [7, 161 and only relevant data will be summarised here. The first follow-up examination involved 7,038 male employees of the Paris Civil Service, aged 43-54 years, without any cardiovascular disease diagnosed at examination [8] . It included a 0-2 h 75 g oral glucose tolerance test with measurement of plasma insulin [17] and glucose levels [18] beside the major CHD risk factors (blood pressure, smoking habits, body mass index (weight (kg)/height2(m)), plasma cholesterol [19] and plasma triglyceride [20] levels). All deaths up to January 1st 1983 were counted (mean followup: 11 years). Deaths were systematically reported by the different administrative departments of the Paris Civil Service.
Complementary inquiries to families, practitioners or hospitals were organized to obtain information regarding the circumstances and causes of death. Coding was performed by a panel of physicians according to the International Classification of Diseases (8th revi- a 1980 WHO classification; b Cox survival analysis; C Mean and mean+2 SEM were computed in natural log values, then transformed into the original units n = Number of patients studied sion); in the present analysis, only deaths caused by CHD to a large extent (410.0-414.9:myocardial infarction; 795.0:sudden death; 782.0-782.9, 427.0, 427.1,519.1 :heart failure) were considered. Among the 7,038 men attending the first follow-up examination, 135 were already known diabetics, and the remaining were classified from the 0-2 h oral glucose tolerance test results (WHO criteria 1980 [2] ) into a group with normal glucose tolerance (n= 6,055), a group with impaired glucose tolerance (IGT, n=690), and a group with newly-diagnosed diabetes (n=158). Subjects with impaired glucose tolerance or known or newly-diagnosed diabetes were selected for the present analysis and grouped together in an 'abnormal glucose tolerance' group. Those with missing values for a variable used in analyses were excluded. Insulin-treated diabetic subjects (n = 10) were also excluded, since the presence of exogenous insulin interfered with the interpretation of plasma insulin values. Altogether, 943 subjects with 'abnormal glucose tolerance' were considered for the present analysis, among whom 26 died from CHD during the follow-up.
Because of the narrow range of age of the population, no adjustment for age was made in univariate analyses. However, in the multivariate analysis using the Cox regression model [21] -BMDP 1981, statistical software P2L -, age was systematically introduced into the equation.
Results

A) Rationale for the grouping together of subjects with impaired glucose tolerance or diabetes
Before proceeding to the analysis of CHD risk factors in subjects with impaired glucose tolerance or diabetes, the question was raised as whether they could be considered as a single group in regard to CHD risk.
It appeared that CHD mortality rates were nearly identical for subjects with IGT and subjects with newlydiagnosed diabetes (Table 1) , the higher mortality rate for diabetic subjects as a whole deriving from the high mortality rate observed for subjects with known diabetes. In terms of specific causes of death (myocardial infarction, sudden death, heart failure), only mortalky rates for sudden death differed significantly with the degree of glucose tolerance. The annual mortality rate for sudden death was 1.6 per 1,000 for subjects with IGT (12 deaths), in comparison to 0.8 per 1,000 for subjects with normal glucose tolerance (51 deaths), and to 2.3 per 1,000 (4 deaths) and 2.1 per 1,000 (3 deaths) in newly-diagnosed and known diabetic subjects respectively. In terms of level of CHD risk factors, again those for subjects with IGT were generally closer to the levels of subjects with diabetes than to the levels of subjects with normal glucose tolerance (Table 1) .
Thus, the group of subjects with either impaired glucose tolerance or diabetes appeared relatively homogeneous in regard to the risk of CHD.
B) Cardiovascular risk factors in subjects with abnormal glucose tolerance
The mean plasma levels of potential risk factors of CHD death in subjects with abnormal glucose tolerance (n = 943) were compared between those who died of CHD (group A, n=26) and those who did not (group B, n = 917) ( Table 2) . Only plasma triglyceride, plasma cholesterol and plasma insulin levels (fasting and 2-h post-load) were significantly higher in group A. Whereas the correlation coefficient between cholesterol and insulin levels was rather weak (r = -0.05 with fasting insulin, p> 0.1; r= -0.02 with 2-h post-load insulin, p> 0.5), it was stronger between triglyceride and cholesterol levels (r=0.36, p<0.0001), and between triglyceride and insulin levels (r= 0.28 with fasting insulin, p< 0.0001 ; r= 0.18 with 2-h post-load insulin, p < 0.0001). When grossly adjusting for triglyceride level (in two equal-sized groups, below and above the median of the triglyceride distribution: 1.39 mmol/1), both cholesterol and insulin levels seemed to retain a predictive value on subsequent CHD death for subjects in the upper half of triglyceride distribution (Figs. J and 2) . However, the multivariate analysis showed that the only variable significantly associated with CHD mortality risk was triglyceridaemia, independently of all other variables indicated in Table 2 . The fit of the model was not significantly improved by the introduction of cholesterol (%2= 1.89, 1 df) or insulin, either fasting or 2-h post-load (Z 2 ---2.79, 1 dO, or both (Z 2 = 5.49, 2 d 0.
Other potential confounding variables, not directly related to cardiovascular risk but known to increase triglyceride plasma level, were ascertained in the 943 subjects. At the time when triglyceride plasma level was measured, antihypertensive treatment was used regularly by 44 subjects, 2 in group A, 42 in group B (p> 0.5). Liver condition had been assessed clinically at entry, and 107 subjects had signs of alcoholic intoxication, 4 in group A, 103 in group B (p> 0.5). Therefore, it was unlikely that the cardiovascular risk associated with high triglyceride plasma levels could be mediated through those parameters.
Thus, hypertriglyceridaemia appeared as a major risk factor of CHD death in subjects with abnormal glucose tolerance. Indeed, as shown in Figure 3 , the distribution of' triglyceride level in group A was clearly shifted to the right compared to the distribution in group B. Most of the subjects in group A (73%) had a plasma triglyceride level over 1.5 mmol/l, whereas plasma triglyceride level was below 1.5 mmol/1 for 56% of the subjects in group B. The relative risk of subsequent CHD death for subjects with a triglyceride level over 1.5 mmol/1 was 3.28 (p< 0.01).
Discussion
The present analysis of the Paris Prospective Study emphasizes the relation of dyslipidaemia and the occurrence of coronary heart disease in subjects with impaired glucose tolerance or diabetes. In this particular population, which is probably in part heterogeneous, but shares common metabolic abnormalities and an increased risk for CHD [22] [23] [24] , an elevated plasma triglyceride level proved to be the strongest predictor of CHD death. The lack of power of the analysis, due to the relatively small number of deaths, may have concealed an independent contribution of insulin and cholesterol plasma levels to In non-diabetic populations, the relationship between triglyceride plasma level and cardiovascular risk generally appears to be mediated through other metabolic abnormalities [27] . This statement also applies to the results of the global analysis of the Paris Prospective Study [7, 8] . However, there may be some particular metabolic situations where hypertriglyceridaemia is an independent marker of CHD risk [28] . For example, it has already been shown with the data of the Paris Prospective Study that plasma triglyceride level was an independent predictor of CHD mortality risk in subjects with a low plasma cholesterol level [29] . This predictive value could be due to the inverse relationship between triglyceride-rich lipoproteins and high-density lipoproteins [30, 31] , since high HDL levels have been shown to be associated with a lower cardiovascular risk [32] .
Both high triglyceride levels and low HDL concentrations are typically found in non-insulin-dependent diabetes and impaired glucose tolerance [33] [34] [35] . This particular form of dyslipidaemia could be related to an impairment of insulin action, one of the key factors in the regulation of lipoproteins metabolism [30, 36] , and accumulating evidence tends to make it a marker of insulin resistance [37] [38] [39] [40] . It may possibly be a causal factor of coronary artery disease, by itself [41] , or through the atherogenicity of VLDL catabolism remnants [42] , or because of the enrichment of HDL particles with triglyceride rather than cholesterol, which could lower their capacity for cholesterol uptake and therefore deteriorate their antiatherogenic power [43] . Keeping in mind that insulinaemia was an independent risk factor of CHD death in the global analysis of the Paris Prospective Study [7, 8] , and that CHD mortality risk was clearly higher in hyperinsulinaemic-hypertriglyceridaemic subjects with abnormal glucose tolerance (Fig. 2) , the results of the present analysis support the hypothesis that the increased risk of coronary artery disease in subjects with abnormal glucose tolerance is due to the clustering of cardiovascular risk factors associated with insulin resistance [44] [45] [46] [47] .
The increase in CHD mortality risk with triglyceride plasma concentration in subjects with impaired glucose tolerance or diabetes awaits confirmation from other prospective studies. However, if it proves stable, such a dyslipidaemia should be sought in this population as a simple way of identifying those who are more "at risk" of coronary heart disease. Preventive interventions are still to be defined, but an appropriate guideline might be to reduce insulin resistance and/or to improve lipoprotein profile by way of diet, exercise, and possibly drugs [48] [49] [50] [51] .
